絞り込み

16555

広告

Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies.

著者 McCullough KB , Hobbs MA , Abeykoon JP , Kapoor P
Curr Hematol Malig Rep.2018 Feb 15 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (248view , 0users)

Full Text Sources

The purpose of this review was to evaluate management strategies for common adverse effects of novel therapies in multiple myeloma (MM), including immunomodulatory drugs, proteasome inhibitors, monoclonal antibodies, and a histone deacetylase inhibitor.
PMID: 29450683 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード